Test Price
2,800 AEDโ Home Collection Available
๐ Results in 3โ4 weeks
COL12A1 Gene Ullrich Congenital Muscular Dystrophy Type 2 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- โAccuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- โPremium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- โClinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed experts.
- โInsurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The COL12A1 gene test uses Next Generation Sequencing to detect pathogenic variants responsible for Ullrich congenital muscular dystrophy type 2, a severe early-onset neuromuscular disorder. This advanced genetic analysis empowers neurologists, pediatricians, and genetic counselors to confirm diagnosis, guide treatment, and inform family planning with precision.
| Feature | Our Test (COL12A1 NGS) | Closest Alternative (Muscle Biopsy with IHC) |
|---|---|---|
| Precision | 99.9% sensitivity for COL12A1 variants | Variable; may miss collagen VI-related subtypes |
| Method | NGS (DNA-based, non-invasive sample) | Invasive muscle biopsy, IHC staining |
| Turnaround Time | 3โ4 weeks | 2โ6 weeks plus histological review |
| Clinical Utility | Confirms molecular diagnosis, carrier testing, prenatal options | Ancillary; may require additional genetic confirmation |
Physician Insight & Safety Protocols
Clinical Correlation Note from Consultant Medical Genetics Lina Osama Zaki Quteineh (DHA: 9294403): Genetic testing for COL12A1 provides a definitive molecular diagnosis for Ullrich congenital muscular dystrophy type 2. However, results must always be correlated with a thorough neuromuscular examination, electrophysiological studies, and muscle imaging. A collaborative approach between the geneticist and the referring physician ensures optimal patient outcomes.
Advisory Guidance on Treatment Continuity
! Do not discontinue prescribed medication or modify treatment plans without consulting your supervising physician. This genetic test is diagnostic and does not override clinical management.
Exclusion Criteria & Clinical Red Flags
- Not intended for asymptomatic individuals under 18 without documented clinical suspicion. Genetic counselling is mandatory prior to testing.
- If the patient experiences acute respiratory distress, severe hypotonia with feeding difficulties, or joint contractures interfering with daily activities, seek emergency care immediately; this test result does not replace urgent intervention.
- Results must be disclosed by a qualified healthcare professional in a structured genetic counselling session. Direct-to-consumer interpretation without medical oversight is prohibited.
Patient FAQ & Clinical Guidance
1. How quickly can I receive my COL12A1 genetic test results in Dubai or Abu Dhabi?
Your NGS-based COL12A1 Ullrich CMD type 2 report is delivered within 3 to 4 weeks from the moment our ISO-certified lab receives your blood, extracted DNA, or FTA card sample. Your clinician will receive a comprehensive molecular report detailing all detected variants.
2. What does the COL12A1 test cover that a muscle biopsy might miss?
This NGS assay specifically sequences the entire coding region of COL12A1 to identify pathogenic variants causing Ullrich congenital muscular dystrophy type 2, which a standard muscle biopsy with collagen VI immunostaining can sometimes overlook due to secondary protein deficiencies.
3. Is home sample collection available and covered by insurance for this genetic test?
Yes, our VIP mobile phlebotomy service performs hospital-grade home collection across all Emirates from 8 AM to 11 PM. We verify direct insurance billing via WhatsApp at +971 54 548 8731 before your appointment.
4. Who should consider this COL12A1 genetic test?
This test is indicated for individuals presenting with clinical features suggestive of Ullrich congenital muscular dystrophy type 2, including early-onset hypotonia, joint contractures, and progressive muscle weakness. It is also offered for carrier testing and reproductive planning in families with known COL12A1 mutations.
UAE Regulatory & Data Privacy Adherence
All genetic testing services at DNA Labs UAE comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability. All processing is performed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139).
ยฉ 2026 โ All clinical information is reviewed by DHA-licensed Consultant Medical Genetics Lina Osama Zaki Quteineh (DHA Registration ID: 9294403). Not for self-diagnosis. Always consult a qualified healthcare provider.
Clinical & Logistical Metadata
| Test Name | COL12A1 Gene Ullrich Congenital Muscular Dystrophy Type 2 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Peripheral whole blood, extracted DNA, or FTA card |
| Methodology Used | Next Generation Sequencing (NGS) โ full coding region analysis |
| ICD-10-CM Code | G71.0 |
| LOINC Code | 74834-3 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["Genetic counselling is mandatory prior to testing"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians